Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Product Update: Harpin

12 Dec 2011 07:00

RNS Number : 7406T
Plant Health Care PLC
12 December 2011
 



12 December, 2011

 

Plant Health Care plc

("Plant Health Care" or the "Company")

 

INDEPENDENT VERIFICATION THAT PLANT HEALTH CARE'S HARPIN SEED TREATMENT, WHEN USED IN COMBINATION WITH INDUSTRY STANDARD SEED TREATMENTS, INCREASES SOYBEAN YIELDS BEYOND STANDARDS ALONE

 

 

Plant Health Care (AIM: PHC), a leading provider of naturally-derived products to the agriculture industry, announces that yield data from Direct Enterprises, Inc. ("DEI"), Monsanto's exclusive distributor of N-Hibit® HX-209 (Harpin αβ protein) dry formulated seed treatment, shows that Plant Health Care's Harpin seed treatment technology delivers added yield, over and above traditional insecticide/fungicide seed treatment combinations.

 

According to Bill Haubner, President of DEI: "Our 2011 field trial once again demonstrates that N-Hibit HX-209 enhances the performance of every insecticide/fungicide combination we tested. All our tests are replicated using standard, Random Complete Block design, and they're conducted from planting through harvest by independent contract researchers, With data from 33 different testing locations across the Midwest, ranging from South Dakota to Ohio, and all states in-between, there's enough for us to say that not only does N-Hibit HX-209 increase soybean yields, when it's used in combination with industry standard insecticide/fungicide treatments, it adds substantially to the yield increases normally associated with those treatments."

 

DEI reports that when N-Hibit HX-209 was added to the most widely used combination soybean insecticide/fungicide seed treatment, the addition of N-Hibit resulted in a yield increase of 2.8 bushels per acre versus the same treatment without harpin. When N-Hibit HX-209 was used with the second-most widely used insecticide/fungicide seed treatment in the USA soybean market, the yield difference jumped to 3.7 bushels per acre versus the same combination without N-Hibit HX-209.

 

John Brady, CEO of Plant Health Care states that: "This independent verification from DEI confirms what we've always known; the addition of Harpin to soybeans boosts yields. Whether used alone, or in combination with the best insecticide/fungicide combinations, Harpin seed treatment delivers value to soybean farmers. It also validates Monsanto's choice to continue making Harpin seed treatment available to American soybean growers via the downstream treatment market while we're working to develop a liquid Harpin formulation that satisfies Monsanto's requirement for upstream use. "

 

DEI, based in Westfield, Indiana, is a key distributor of seed enhancements and application equipment in the USA. Please visit www.go2dei.com to see the complete data set that shows the results of all treatments at each location.

 

- ENDS -

 

 

For further information, please contact:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

 

 

Evolution Securities

Tavistock Communications

Tim Worlledge/Jeremy Ellis/Adam James

Jeremy Carey/Simon Compton

Tel: +44-20-7071-4300

Tel: +44-20-7920-3150

jcarey@tavistock.co.uk

scompton@tavistock.co.uk

 

 

 

About Plant Health Care plc: Plant Health Care is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, Plant Health Care currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

Plant Health Care's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAXANELKFFFF
Date   Source Headline
2nd Jul 20242:23 pmRNSForm 8.3 - Plant Health Care plc
1st Jul 20249:46 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20247:32 amRNSForm 8.3 - Plant Health Care plc
28th Jun 20241:38 pmRNSForm 8.3 - Plant Health Care PLC
28th Jun 202411:35 amRNSForm 8.3 - Plant Health Care plc
28th Jun 202411:31 amRNSResult of GM & AGM
28th Jun 202410:13 amRNSForm 8.3 - Plant Health Care Plc
28th Jun 20249:16 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 20248:59 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20241:03 pmPRNForm 8.3 - Plant Health Care Plc
27th Jun 202412:13 pmRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:43 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:08 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20245:55 pmRNSForm 8.3 - Plant Health Care
26th Jun 20241:23 pmRNSRecommended Cash Acquisition of Plant Health Care
12th Jun 20245:22 pmRNSNotice of General Meeting
5th Jun 20245:09 pmRNSNotice of Annual General Meeting
4th Jun 20247:00 amRNSExpanded New California Label for Employ®
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.